Vitiligo. Vitiligo
Conditions
Interventions
Intervention 1: Intervention group: The intervention group will receive a topical serum containing 3% adipose-derived mesenchymal stem cell medium, twice a day for 45 days. Intervention 2: Control gro
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 18 Years and older Diagnosis of Vitiligo - Generalized vitiligo involving both sides of the body in one or more areas of the body (limbs, trunk, etc.) Be able to understand the requirements of the study and be able to sign an informed consent form Agree to follow the terms of the study and follow-up Lack of corticosteroid-based treatment
Exclusion criteria
Exclusion criteria: Pregnant females Infection in donor site Kubner's evidence in the past Keloidal tendency Patients with focal or segmental vitiligo are defined as vitiligo that affects only one area of the body on one side of the body Patients with vitiligo that affects more than 30% of their body surface Patients who self-reported HIV or hepatitis C Patients self-reported having uncontrolled diabetes mellitus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of skin repigmentation through skin biometry. Timepoint: Before and after of inerventation and 3 months after study completion. Method of measurement: Skin Biometry by using MPA9 probe. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahsa Mollapour Sisakht
Tehran University of Medical Sciences
Outcome results
None listed